Edison Investment Research Limited (LON:KEFI) | Finanzwire

Basculer en Français

8306	Companies
115328	Keywords
55598	Articles
62614	Press releases

Headlines Articles Press releases Edison Investment Research Limited

Home
Companies
Edison Investment Research Limited

BRIEF

published on 02/29/2024 at 14:06, 8 months 22 days ago

Edison Investment Research Initiates Coverage on Good Life Plus with Optimism

Growth Strategy UK Market Edison Investment Research Good Life Plus Business Valuation
PRESS RELEASE

published on 02/29/2024 at 14:06, 8 months 22 days ago

Edison issues initiation on Good Life Plus (GDLF): Welcome to the Goodlife!
Edison issues initiation on Good Life Plus (GDLF), an early-stage entertainment-focused subscription-based prize draw operator in the UK, founded in 2021. The report provides insights into the company's growth strategy, financial projections, and market opportunity

Edison Good Life Plus GDLF Subscription-based Entertainment-focused
BRIEF

published on 02/29/2024 at 12:27, 8 months 22 days ago

Impressive Performance of The Law Debenture Corporation in FY23

Financial Performance DPS Growth The Law Debenture Corporation Investing In UK Stocks Analysis By Edison Investment Research
PRESS RELEASE

published on 02/29/2024 at 12:27, 8 months 22 days ago

Edison issues review on The Law Debenture Corporation (LWDB): One plus one equals three
Edison issues review on The Law Debenture Corporation (LWDB): FY23 results show outperformance, strong growth prospects in UK equities. Click for full report

Edison Investment Research Limited Investment Trust FY23 Results The Law Debenture Corporation UK Equities
BRIEF

published on 02/23/2024 at 16:57, 8 months 28 days ago

Georgia Capital announces strong performance in FY23 with a 20% increase in its NAV

Financial Performance Stock Market NAV Georgia Capital Bank Of Georgia
PRESS RELEASE

published on 02/23/2024 at 16:57, 8 months 28 days ago

Edison issues update on Georgia Capital (CGEO): FY23 NAV TR of 20% in sterling terms
Edison issues update on Georgia Capital (CGEO): FY23 NAV TR of 20% in sterling terms. GCAP's NAV TR sees considerable increase in sterling terms, trading at discount to NAV

NAV Total Return Georgia Capital CGEO Sterling Terms Discount
BRIEF

published on 02/22/2024 at 13:36, 9 months ago

Edison Investment Research initiates coverage of Cereno Scientific with a differentiated approach in cardiovascular diseases

Investment Cardiovascular Diseases Cereno Scientific Valproic Acid Biotechnological Research
PRESS RELEASE

published on 02/22/2024 at 13:36, 9 months ago

Edison issues initiation on Cereno Scientific (CRNO B): Differentiated approach in CVD with potential
Edison initiates coverage on Cereno Scientific, a biotech company focused on cardiovascular disease treatments with innovative approaches. Key assets include CS1 for PAH. Financial analysis projects positive growth

Biotech Cardiovascular Diseases Edison Cereno Scientific CS1
PRESS RELEASE

published on 02/15/2024 at 11:57, 9 months 7 days ago

Edison issues review on Finsbury Growth & Income Trust (FGT): Looking forward to improved relative performance
Edison issues review on Finsbury Growth & Income Trust (FGT) and their outlook for improved relative performance. Analysis of management strategy and recent underperformance

Investment Performance Edison Management Finsbury Growth & Income Trust
PRESS RELEASE

published on 02/14/2024 at 13:10, 9 months 8 days ago

Edison issues update on The Diverse Income Trust (DIVI): Manager anticipates a small-cap super cycle
Edison updates on The Diverse Income Trust (DIVI), anticipating a small-cap super cycle. Managers focus on resilient dividend income with potential growth. UK stocks undervalued with upside potential from improved sentiment

Edison Diverse Income Trust DIVI Small-cap Super Cycle UK Stocks

Accesswire

Published on 11/22/2024 at 16:00, 1 hour 49 minutes ago

Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 1 hour 54 minutes ago

Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 2 hours 34 minutes ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 3 hours 4 minutes ago

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 14:30, 3 hours 19 minutes ago

Allied Universal Named Presenting Sponsor of 2024 Lott IMPACT Trophy Recognizing College Football's Defensive Best

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 16:55, 53 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 hour 49 minutes ago

Proposed cancellation of admission to trading
Published on 11/22/2024 at 16:00, 1 hour 49 minutes ago

AlphaX Makes Crypto Easier with Email Login and USDT Memecoins
Published on 11/22/2024 at 15:27, 2 hours 22 minutes ago

EQS-Adhoc: Eckert & Ziegler raises its forecast for the current financial year once again
Published on 11/22/2024 at 14:46, 3 hours 2 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company

Les Echos

Published on 11/22/2024 at 14:35, 3 hours 14 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 1 day 10 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 22 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE